BioForce Nanosciences Holdings, Inc.
BFNH
$0.45
-$0.0471-9.48%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 133.50K | 123.20K | 122.00K | 114.40K | 130.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 133.50K | 123.20K | 122.00K | 114.40K | 130.80K |
| Operating Income | -133.50K | -123.20K | -122.00K | -114.40K | -130.80K |
| Income Before Tax | -934.70K | -123.20K | -122.00K | -114.40K | -130.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -934.70K | -123.20K | -122.00K | -114.40K | -130.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -934.70K | -123.20K | -122.00K | -114.40K | -130.80K |
| EBIT | -133.50K | -123.20K | -122.00K | -114.40K | -130.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 32.25M | 29.27M | 29.27M | 29.27M | 29.27M |
| Average Diluted Shares Outstanding | 32.25M | 29.27M | 29.27M | 29.27M | 29.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |